Intravenous Ketamine-induced Affective Switch in a Patient of Major Depressive Disorder with Suicidal Ideation: A Case Report

Downloads

Published

2022-09-26

DOI:

https://doi.org/10.55229/ijbs.v25i2.14

Keywords:

Major Depressive Disorder, Suicidal ideation, Intravenous, Ketamine, Treatment-emergent affective switch

Dimensions Badge

Issue

Vol. 25 No. 02 (2022): Indian Journal of Behavioural Sciences

Section

CASE REPORT

License

Copyright (c) 2022 Akanksha Varshney, Shravan Kumar, Ved Prakash Gupta, Rehan Mateen, Suhail Ahmad Azmi

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

You are free to:

  • The licensor cannot revoke these freedoms as long as you follow the license terms.

Under the following terms:

  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Crossref
Scopus
Google Scholar
Europe PMC

Authors

  • Akanksha Varshney Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
  • Shravan Kumar Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
  • Ved Prakash Gupta Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
  • Rehan Mateen Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
  • Suhail Ahmad Azmi Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Abstract

In treatment-resistant unipolar and bipolar depression, there is increasing evidence to support the fast, although the short-lived antidepressant effect of ketamine, a non-competitive glutamate N-methyl-D-aspartate receptor antagonist. Ketamine has been shown to cause transient mood elevation or euphoria, dissociative symptoms and psychotomimetic effects when administered in unipolar or bipolar depression. Still, it has not been shown to cause an affective switch resulting in persistent hypomania/mania or a manic-like state. We report the case of a 47-year-old man who developed a switch to mania while receiving a sub-anaesthetic dosage of ketamine intravenously for his third episode of recurrent, non-psychotic severe major depression with suicidal ideation. This case indicates that a polarity switch should be acknowledged as a possible side effect when using ketamine for depression.

How to Cite

Varshney, A., Kumar, S. ., Gupta, V. P. ., Mateen, R. ., & Azmi, S. A. . (2022). Intravenous Ketamine-induced Affective Switch in a Patient of Major Depressive Disorder with Suicidal Ideation: A Case Report. Indian Journal of Behavioural Sciences, 25(02), 158–160. https://doi.org/10.55229/ijbs.v25i2.14

Downloads

Download data is not yet available.

Author Biographies

Shravan Kumar, Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Assistant Professor, Department of Psychiatry, JNMCH, AMU, Aligarh, India

Ved Prakash Gupta, Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Senior Resident, Department of Psychiatry, JNMCH, AMU, Aligarh, India

Rehan Mateen, Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Junior Resident, Department of Psychiatry, JNMCH, AMU, Aligarh, India

Suhail Ahmad Azmi, Department of Psychiatry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

Professor, Department of Psychiatry, JNMCH, AMU, Aligarh, India

 

References

Naughton M, Clarke G, O'Leary OF, Cryan JF, Dinan TG. A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. J Affect Disord 2014;156:24-35.

Serafini G, Howland RH, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: A systematic review. Curr Neuropharmacol 2014;12:444-61.

Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009;11:453-73.

Wada K, Sasaki T, Jitsuiki H, Yoshimura Y, Erabi H, Hada Y, et al. Manic/hypomanic switch during acute antidepressant treatment for unipolar depression. J Clin Psychopharmacol 2006;26:512-5.

Navarro V, Gastó C, Guarch J, Penadés R, Pintor L. Treatment and outcome of antidepressant treatment-associated hypomania in unipolar major depression: A 3-year follow-up study. J Affect Disord 2014;155:59-64.

Niciu MJ, Luckenbaugh DA, Ionescu DF, Mathews DC, Richards EM, Zarate CA Jr. Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression. Biol Psychiatry 2013;74:e23-4.

Ricke AK, Snook RJ, Anand A. Induction of prolonged mania during ketamine therapy for reflex sympathetic dystrophy. Biol Psychiatry 2011;70:e13-4.

Niciu MJ, Luckenbaugh DA, Ionescu DF, Mathews DC, Richards EM, Zarate CA Jr. Subanesthetic Dose Ketamine Does Not Induce an Affective Switch in Three Independent Samples of Treatment-Resistant Major Depression. Biol Psychiatry (2013) 15(74(10)):e23–4. doi: 10.1016/j.biopsych.2013.01.038.

Banwari G, Desai P, Patidar P. Ketamine-induced affective switch in a patient with treatment-resistant depression.Indian J Pharmacol 2015;47:454-455.